New Study Finds Nanoparticles Show Promise in Therapy for Triple-Negative Breast Cancer

Researchers found by encapsulating medication use nanoparticles, treatment is more effective in triple-negative breast cancer cells
October 1, 2018

Adam Friedman, MD, director of the Supportive Oncodermatology Clinic at the GW Cancer Center and professor of Dermatology at the GW School of Medicine and Health Sciences, explains the benefits available with nanotechnology, including new potential strategies for addressing cancer cell drug resistance.